欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号IS/H/0424/001
药品名称Pazopanib AdAlvo
活性成分
    • PAZOPANIB hydrochloride 200.0 mg
剂型Film-coated tablet
上市许可持有人AdAlvo Limited Malta Life Sciences Park Building 1, Level 4 Sir Temi Zammit Buildings San Gwann Industrial Estate, San Gwann SGN 3000, Malta
参考成员国 - 产品名称Iceland (IS)
Pazopanib AdAlvo
互认成员国 - 产品名称
    • Lithuania (LT)
      Pazopanib Alvogen 200 mg plėvele dengtos tabletės
    • Bulgaria (BG)
      Pazopanib Alvogen
    • Romania (RO)
许可日期2021/03/08
最近更新日期2022/12/20
药物ATC编码
    • L01XE11 pazopanib
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Initial Application
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase